BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11764091)

  • 1. Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.
    Atzori C; Ghetti B; Piva R; Srinivasan AN; Zolo P; Delisle MB; Mirra SS; Migheli A
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1190-7. PubMed ID: 11764091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
    Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
    Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.
    Ferrer I
    Neurotox Res; 2004; 6(6):469-75. PubMed ID: 15658002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.
    Lagalwar S; Berry RW; Binder LI
    Acta Neuropathol; 2007 Jan; 113(1):63-73. PubMed ID: 17089132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.
    Puig B; Gómez-Isla T; Ribé E; Cuadrado M; Torrejón-Escribano B; Dalfó E; Ferrer I
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):491-502. PubMed ID: 15488025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    Reynolds CH; Betts JC; Blackstock WP; Nebreda AR; Anderton BH
    J Neurochem; 2000 Apr; 74(4):1587-95. PubMed ID: 10737616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation.
    Ferrer I; Pastor P; Rey MJ; Muñoz E; Puig B; Pastor E; Oliva R; Tolosa E
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):23-34. PubMed ID: 12581337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
    Zhu X; Raina AK; Rottkamp CA; Aliev G; Perry G; Boux H; Smith MA
    J Neurochem; 2001 Jan; 76(2):435-41. PubMed ID: 11208906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Blanco R; Carmona M; Puig B
    Neuropathol Appl Neurobiol; 2001 Oct; 27(5):343-51. PubMed ID: 11679086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau.
    Hartzler AW; Zhu X; Siedlak SL; Castellani RJ; Avilá J; Perry G; Smith MA
    Neurobiol Aging; 2002; 23(5):855-9. PubMed ID: 12392790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition.
    Savage MJ; Lin YG; Ciallella JR; Flood DG; Scott RW
    J Neurosci; 2002 May; 22(9):3376-85. PubMed ID: 11978814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.
    Zhu X; Rottkamp CA; Boux H; Takeda A; Perry G; Smith MA
    J Neuropathol Exp Neurol; 2000 Oct; 59(10):880-8. PubMed ID: 11079778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles.
    Takahashi M; Uchikado H; Caprotti D; Weidenheim KM; Dickson DW; Ksiezak-Reding H; Pasinetti GM
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1157-69. PubMed ID: 17146290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
    Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
    Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abeta(1-42)-induced JNK and ERK activation in rabbit hippocampus is differentially regulated by lithium but is not involved in the phosphorylation of tau.
    Ghribi O; Prammonjago P; Herman MM; Spaulding NK; Savory J
    Brain Res Mol Brain Res; 2003 Nov; 119(2):201-6. PubMed ID: 14625087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.